Cytocom
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cytocom's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 76% to $262,942. The net income raised on -$2,398,457 and profit margin reached -912%. Total operating expenses were $2,849,493.

Profit Margin

Cytocom, Inc. (NASDAQ:CBLI): Profit margin
2011 8.79M -4.01M -45.66%
2012 3.57M -18.23M -510.66%
2013 8.48M -17.26M -203.38%
2014 3.70M 1.62M 44.01%
2015 2.70M -12.63M -466.64%
2016 3.51M -2.65M -75.57%
2017 1.94M -9.70M -498.19%
2018 1.13M -3.61M -317.34%
2019 1.11M -2.64M -237.73%
2020 262.94K -2.39M -912.16%

CBLI Income Statement (2011 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue
Revenue
262.94K1.11M1.13M1.94M3.51M2.70M3.70M8.48M3.57M8.79M
Cost of revenue
0000000000
Gross profit
262.94K1.11M1.13M1.94M3.51M2.70M3.70M8.48M3.57M8.79M
Operating exp.
Research and development
691.07K1.65M3.61M5.04M6.49M7.14M9.65M19.52M22.50M22.78M
Selling and marketing
0000000000
Total operating expenses
2.84M3.47M5.93M7.54M9.87M13.49M18.12M31.56M33.61M33.89M
Operating income
-2.58M-2.36M-4.79M-5.60M-6.35M-10.79M-14.42M-23.07M-30.04M-25.10M
Other income (expenses), net
148.67K-333.82K1.09M-4.24M3.76M-2.25M14.45M2.94M7.63M-19.87M
Income before tax
-2.43M-2.69M-3.70M-9.84M-2.59M-13.04M35.36K-20.12M-22.41M-5.22M
Income tax expense
148.67K-333.82K1.09M-4.24M3.76M-2.15M14.45M2.94M00
Net income
-2.39M-2.64M-3.61M-9.70M-2.65M-12.63M1.62M-17.26M-18.23M-4.01M
Earnings per share
Basic EPS
-0.19-0.23-0.32-0.87-0.24-1.790.6-7.67-9.8-2.4
Diluted EPS
-0.19-0.23-0.32-0.87-0.24-1.790.6-7.67-9.8-2.4
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source